Kelatorphan, a potent enkephalinases inhibitor, presents opposite properties when injected intracerebroventricularly or into the nucleus accumbens on intracranial self-stimulation
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 12 (3) , 347-350
- https://doi.org/10.1016/0197-0186(88)90173-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventriclesNeurochemistry International, 1987
- Bidentate peptides: Highly potent new inhibitors of enkephalin degrading enzymesLife Sciences, 1984
- Dopamine modulates cholecystokinin release in neostriatumNature, 1983
- Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleusNature, 1981
- Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injectionEuropean Journal of Pharmacology, 1980
- A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immunocytochemistryBrain Research, 1980
- The induction of catalepsy and hyperactivity by morphine administered directly into the nucleus accumbens of ratsEuropean Journal of Pharmacology, 1978
- Drugs and Reinforcement Mechanisms: A Critical Review of the Catecholamine TheoryAnnual Review of Pharmacology and Toxicology, 1978
- Determination of methionine enkephalin in discrete regions of rat brainBrain Research, 1977
- Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatusNeuropharmacology, 1977